FR2764287B1 - Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique - Google Patents

Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique

Info

Publication number
FR2764287B1
FR2764287B1 FR9706944A FR9706944A FR2764287B1 FR 2764287 B1 FR2764287 B1 FR 2764287B1 FR 9706944 A FR9706944 A FR 9706944A FR 9706944 A FR9706944 A FR 9706944A FR 2764287 B1 FR2764287 B1 FR 2764287B1
Authority
FR
France
Prior art keywords
naphtalen
dioxanes
derivatives
preparation
therapeutic application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9706944A
Other languages
English (en)
Other versions
FR2764287A1 (fr
Inventor
Gihad Dargazanli
Patrick Lardenois
Jonathan Frost
Pascal George
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9706944A priority Critical patent/FR2764287B1/fr
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to CA002290695A priority patent/CA2290695A1/fr
Priority to SK1661-99A priority patent/SK166199A3/sk
Priority to PL98337234A priority patent/PL337234A1/xx
Priority to CN98807817A priority patent/CN1265658A/zh
Priority to BR9810742-9A priority patent/BR9810742A/pt
Priority to EEP199900560A priority patent/EE9900560A/xx
Priority to KR1019997011436A priority patent/KR20010013435A/ko
Priority to ARP980102585A priority patent/AR012908A1/es
Priority to EP98928419A priority patent/EP0986552A1/fr
Priority to TR1999/03022T priority patent/TR199903022T2/xx
Priority to HU0002166A priority patent/HUP0002166A3/hu
Priority to JP50172399A priority patent/JP2002502412A/ja
Priority to AU80251/98A priority patent/AU8025198A/en
Priority to PCT/FR1998/001113 priority patent/WO1998055474A1/fr
Priority to IL13324298A priority patent/IL133242A0/xx
Priority to CO98031750A priority patent/CO4940480A1/es
Publication of FR2764287A1 publication Critical patent/FR2764287A1/fr
Publication of FR2764287B1 publication Critical patent/FR2764287B1/fr
Application granted granted Critical
Priority to BG103937A priority patent/BG103937A/xx
Priority to NO995966A priority patent/NO995966L/no
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR9706944A 1997-06-05 1997-06-05 Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique Expired - Fee Related FR2764287B1 (fr)

Priority Applications (19)

Application Number Priority Date Filing Date Title
FR9706944A FR2764287B1 (fr) 1997-06-05 1997-06-05 Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
JP50172399A JP2002502412A (ja) 1997-06-05 1998-06-03 ５−ナフタレン−１−イル−１，３−ジオキサン誘導体、製造方法および治療用途
HU0002166A HUP0002166A3 (en) 1997-06-05 1998-06-03 5-naphthalen-1-yl-1,3-dioxane derivatives and pharmaceutical compositions thereof
CN98807817A CN1265658A (zh) 1997-06-05 1998-06-03 5－萘－1－基－1,3－二噁烷衍生物、它们的制备方法以及它们在治疗中的应用
BR9810742-9A BR9810742A (pt) 1997-06-05 1998-06-03 Derivados de 5-naftalen -1il-1,3-dioxana, preparação dos mesmos e aplicação em terapia
EEP199900560A EE9900560A (et) 1997-06-05 1998-06-03 5-naftaleen-1-üül-1,3-dioksaani derivaadid, nende valmistamine ja terapeutiline kasutamine
KR1019997011436A KR20010013435A (ko) 1997-06-05 1998-06-03 5-나프탈렌-1-일-1,3-디옥산 유도체, 제조 및 치료에의 이용
SK1661-99A SK166199A3 (en) 1997-06-05 1998-06-03 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
EP98928419A EP0986552A1 (fr) 1997-06-05 1998-06-03 Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique
AU80251/98A AU8025198A (en) 1997-06-05 1998-06-03 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
CA002290695A CA2290695A1 (fr) 1997-06-05 1998-06-03 Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique
PL98337234A PL337234A1 (en) 1997-06-05 1998-06-03 Derivatives of 5-naphtalen-1-yl-1,3-dioxane, their production and therapeutic application
TR1999/03022T TR199903022T2 (xx) 1997-06-05 1998-06-03 5-Naftalin-1-il-1, 3-diokzan t�revleri, haz�rlamalar� ve terap�tik uygulamalar�.
PCT/FR1998/001113 WO1998055474A1 (fr) 1997-06-05 1998-06-03 Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique
IL13324298A IL133242A0 (en) 1997-06-05 1998-06-03 5-Naphthalene-1-yl-1,3-dioxane derivatives their preparation and their therapeutic application
ARP980102585A AR012908A1 (es) 1997-06-05 1998-06-03 Un compuesto derivado de 5-naftalen-1-il-1,3-dioxano bajo la forma de estereoisomero puro o de mezcla de estereoisomeros, medicamento que consisteen dicho compuesto, y composicion farmaceutica que contiene a dicho compuesto
CO98031750A CO4940480A1 (es) 1997-06-05 1998-06-04 Derivados de 5-naftalen-1-il-1,3-dioxano y su preparacion .
BG103937A BG103937A (en) 1997-06-05 1999-11-30 5-naphthalen-1-yl-1,3-dioxane derivatives, their preparation and application in therapy
NO995966A NO995966L (no) 1997-06-05 1999-12-03 5-naftalen-1-yl-1,3-dioksan-derivater, deres fremstilling og terapeutisk anvendelse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9706944A FR2764287B1 (fr) 1997-06-05 1997-06-05 Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2764287A1 FR2764287A1 (fr) 1998-12-11
FR2764287B1 true FR2764287B1 (fr) 1999-07-16

Family

ID=9507626

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9706944A Expired - Fee Related FR2764287B1 (fr) 1997-06-05 1997-06-05 Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique

Country Status (1)

Country Link
FR (1) FR2764287B1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0461958B1 (fr) * 1990-06-15 1994-09-14 Synthelabo Dérivés de 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanes, leur préparation et leur application en thérapeutique

Also Published As

Publication number Publication date
FR2764287A1 (fr) 1998-12-11

Similar Documents

Publication Publication Date Title
FR2791678B1 (fr) Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
FR2786770B1 (fr) Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2790474B1 (fr) Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
FR2786769B1 (fr) Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
FR2786482B1 (fr) Nouveaux derives de 2-pyridone, leur preparation et leur application en therapeutique
FR2728900B1 (fr) Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique
FR2809730B1 (fr) Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
FR2766823B1 (fr) Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2756563B1 (fr) Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2761071B1 (fr) Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2753970B1 (fr) Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
FR2761068B1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
FR2737494B1 (fr) Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
FR2752839B1 (fr) Derives de benzofurane, leur preparation et leur application en therapeutique
FR2742152B1 (fr) Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2761070B1 (fr) Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique
FR2772378B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2724382B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
FR2785903B1 (fr) Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique
FR2792635B1 (fr) Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2792634B1 (fr) Derives de 2-alcoxy-cyclobutene-3,4-dione leur preparation et leur application en therapeutique
FR2759698B1 (fr) Derives de 1,4-diphenylimidazole-5-acetamide, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse